Drug · DIN 02486512
RAMIPRIL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 13, 2022; first marketed March 19, 2020.
- Drug Identification Number (DIN)
- 02486512
- Company (DIN owner)
- Altamed PharmaBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Ramipril C09AA05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RAMIPRIL | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 12, 2019: NOC 21960Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named RAMIPRIL
- DIN 02255316 · Marketed
- DIN 02255324 · Marketed
- DIN 02255332 · Marketed
- DIN 02287927 · Marketed
- DIN 02287935 · Marketed
- DIN 02287943 · Marketed
- DIN 02308363 · Marketed
- DIN 02299372 · Dormant
- DIN 02342685 · Cancelled Pre Market
- DIN 02342693 · Cancelled Pre Market
- DIN 02342707 · Cancelled Pre Market
- DIN 02342715 · Cancelled Pre Market
- DIN 02374846 · Cancelled Post Market
- DIN 02374854 · Cancelled Post Market
- DIN 02374862 · Cancelled Post Market
- DIN 02469553 · Approved
- DIN 02486504 · Cancelled Pre Market
- DIN 02486520 · Cancelled Post Market
- DIN 02486539 · Cancelled Post Market
- DIN 02486547 · Cancelled Pre Market